Operating Expenses Summary of SCI Pharmtech, Inc.

SCI Pharmtech, Inc.'s latest annual operating expenses in 2023 was 190.02 Million TWD , up 10.34% from previous year.
SCI Pharmtech, Inc.'s latest quarterly operating expenses in 2024 Q2 was 45.35 Million TWD , up 12.87% from previous quarter.
SCI Pharmtech, Inc. reported a annual operating expenses of 172.2 Million TWD in annual operating expenses 2022, up 28.1% from previous year.
SCI Pharmtech, Inc. reported a annual operating expenses of 134.43 Million TWD in annual operating expenses 2021, down -39.97% from previous year.
SCI Pharmtech, Inc. reported a quarterly operating expenses of 46.84 Million TWD for 2024 Q1, down -19.9% from previous quarter.
SCI Pharmtech, Inc. reported a quarterly operating expenses of 43.89 Million TWD for 2023 Q3, up 1.1% from previous quarter.

Annual Operating Expenses Chart of SCI Pharmtech, Inc. (2023 - 2009)

Historical Annual Operating Expenses of SCI Pharmtech, Inc. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	190.02 Million TWD	10.34%
2022	172.2 Million TWD	28.1%
2021	134.43 Million TWD	-39.97%
2020	223.92 Million TWD	-6.17%
2019	238.64 Million TWD	2.78%
2018	232.19 Million TWD	44.1%
2017	161.14 Million TWD	-41.2%
2016	274.06 Million TWD	27.26%
2015	215.36 Million TWD	17.05%
2014	183.98 Million TWD	-3.73%
2013	191.12 Million TWD	30.87%
2012	146.03 Million TWD	20.57%
2011	121.11 Million TWD	4.17%
2010	116.27 Million TWD	-0.36%
2009	116.68 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	45.35 Million TWD	12.87%
2024 Q1	46.84 Million TWD	-19.9%
2023 Q3	43.89 Million TWD	1.1%
2023 Q4	58.48 Million TWD	33.25%
2023 Q1	44.23 Million TWD	-0.98%
2023 Q2	43.41 Million TWD	-1.84%
2023 FY	190.02 Million TWD	10.34%
2022 Q2	44.69 Million TWD	21.01%
2022 FY	172.2 Million TWD	28.1%
2022 Q1	36.93 Million TWD	25.88%
2022 Q4	44.66 Million TWD	-2.7%
2022 Q3	45.9 Million TWD	2.71%
2021 Q1	38.48 Million TWD	819.0%
2021 Q3	37.4 Million TWD	28.14%
2021 Q2	29.19 Million TWD	-24.15%
2021 FY	134.43 Million TWD	-39.97%
2021 Q4	29.34 Million TWD	-21.56%
2020 FY	223.92 Million TWD	-6.17%
2020 Q2	86.27 Million TWD	10.3%
2020 Q3	64.79 Million TWD	-24.9%
2020 Q4	-5.35 Million TWD	-108.26%
2020 Q1	78.21 Million TWD	66.57%
2019 Q1	71.54 Million TWD	68.02%
2019 Q4	46.95 Million TWD	-25.53%
2019 FY	238.64 Million TWD	2.78%
2019 Q3	63.05 Million TWD	10.45%
2019 Q2	57.09 Million TWD	-20.2%
2018 Q3	60.96 Million TWD	-21.09%
2018 FY	232.19 Million TWD	44.1%
2018 Q4	42.58 Million TWD	-30.15%
2018 Q2	77.25 Million TWD	50.3%
2018 Q1	51.4 Million TWD	32.32%
2017 Q4	38.84 Million TWD	-23.64%
2017 FY	161.14 Million TWD	-41.2%
2017 Q1	35.29 Million TWD	-32.85%
2017 Q2	36.12 Million TWD	2.33%
2017 Q3	50.87 Million TWD	40.83%
2016 Q1	95.01 Million TWD	102.04%
2016 Q3	63.37 Million TWD	0.41%
2016 Q4	52.56 Million TWD	-17.05%
2016 FY	274.06 Million TWD	27.26%
2016 Q2	63.11 Million TWD	-33.58%
2015 Q1	53.88 Million TWD	30.65%
2015 Q2	64.17 Million TWD	19.1%
2015 FY	215.36 Million TWD	17.05%
2015 Q3	50.27 Million TWD	-21.67%
2015 Q4	47.02 Million TWD	-6.45%
2014 Q2	50.52 Million TWD	-0.65%
2014 Q4	41.24 Million TWD	-0.27%
2014 FY	183.98 Million TWD	-3.73%
2014 Q1	50.85 Million TWD	14.87%
2014 Q3	41.35 Million TWD	-18.15%
2013 FY	191.12 Million TWD	30.87%
2013 Q3	70.02 Million TWD	84.8%
2013 Q4	44.27 Million TWD	-36.77%
2013 Q2	37.89 Million TWD	-2.66%
2013 Q1	38.92 Million TWD	3.41%
2012 Q2	34.35 Million TWD	-15.03%
2012 Q1	40.42 Million TWD	69.18%
2012 Q4	37.64 Million TWD	11.51%
2012 Q3	33.76 Million TWD	-1.73%
2012 FY	146.03 Million TWD	20.57%
2011 Q3	31.25 Million TWD	7.54%
2011 Q1	36.89 Million TWD	31.08%
2011 Q2	29.06 Million TWD	-21.22%
2011 FY	121.11 Million TWD	4.17%
2011 Q4	23.89 Million TWD	-23.55%
2010 FY	116.27 Million TWD	-0.36%
2010 Q2	33.01 Million TWD	24.05%
2010 Q1	26.61 Million TWD	0.0%
2010 Q4	28.14 Million TWD	-1.25%
2010 Q3	28.5 Million TWD	-13.65%
2009 FY	116.68 Million TWD	0.0%

Peer Operating Expenses Comparison of SCI Pharmtech, Inc.

Name	Operating Expenses	Operating Expenses Difference
Grape King Bio Ltd	6.03 Billion TWD	96.854%
Standard Chem & Pharm CO., LTD.	1.46 Billion TWD	87.036%
Maywufa Company Ltd.	854.37 Million TWD	77.759%
ScinoPharm Taiwan, Ltd.	901.49 Million TWD	78.921%
Lotus Pharmaceutical Co., Ltd.	4.48 Billion TWD	95.759%
LIWANLI Innovation Co., Ltd.	54.86 Million TWD	-246.34%
YungShin Global Holding Corporation	2.04 Billion TWD	90.72%
PhytoHealth Corporation	67.64 Million TWD	-180.92%
Formosa Laboratories, Inc.	1.24 Billion TWD	84.778%
PharmaEssentia Corporation	4.49 Billion TWD	95.773%
Bora Pharmaceuticals Co., LTD.	1.74 Billion TWD	89.092%

Global Stocks Search

SCI Pharmtech, Inc. (4119.TW)

Operating Expenses Summary of SCI Pharmtech, Inc.

Annual Operating Expenses Chart of SCI Pharmtech, Inc. (2023 - 2009)

Historical Annual Operating Expenses of SCI Pharmtech, Inc. (2023 - 2009)

Peer Operating Expenses Comparison of SCI Pharmtech, Inc.